BRIGHT MINDS BIOSCIENCES INC. insider trading activity

Understanding Insider Activity at BRIGHT MINDS BIOSCIENCES INC.

Welcome to our dedicated page for BRIGHT MINDS BIOSCIENCES INC. (Nasdaq: DRUG) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by BRIGHT MINDS BIOSCIENCES INC.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for BRIGHT MINDS BIOSCIENCES INC., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for DRUG
TickerTime & DateFilingLink
DRUG9:20:48 PM, 11/6/2024
Cormorant Asset Management, LP purchased 184331 shares of BRIGHT MINDS BIOSCIENCES INC. (DRUG) for ~$3999982
Filing
DRUG9:11:29 PM, 10/17/2024
Cormorant Asset Management, LP purchased 422591 shares of BRIGHT MINDS BIOSCIENCES INC. (DRUG) for ~$3233754
Filing